Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The products will be manufactured at the company's facility in Bengaluru
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
The hospital hosted a two-day event with top internal and external faculty and medical experts
The inspection was a cGMP Inspection and had ended with NIL observations
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Subscribe To Our Newsletter & Stay Updated
